Intestinal tight junction protein network (TJ network)

The intestinal tight junction protein network is a complex multi-protein assembly located at the apical-lateral membrane of epithelial cells, serving as the primary determinant of the intestinal paracellular barrier [1, 6]. It consists of transmembrane proteins such as claudins, occludin, and junctional adhesion molecules (JAMs), which are anchored to the actin cytoskeleton via cytoplasmic scaffolding proteins like zonula occludens (ZO-1, ZO-2, ZO-3) [1, 18]. This network dynamically regulates the selective passage of water, ions, and nutrients while preventing the translocation of luminal pathogens, toxins, and antigens into the systemic circulation [7, 10]. Dysregulation of this network, often referred to as intestinal hyperpermeability or "leaky gut," is a critical factor in the pathogenesis of inflammatory bowel disease (IBD), celiac disease, and various systemic autoimmune conditions [4, 11, 18]. Therapeutic targeting of the network involves stabilizing these junctions or preventing their disassembly, with emerging drugs like larazotide acetate acting as zonulin antagonists and lubiprostone promoting barrier repair through chloride channel activation [13, 16].

Other names

Tight junction complexIntestinal paracellular barrierZonula occludensEpithelial junctional complexIntestinal mucosal barrier

Modulation of paracellular permeability through zonulin antagonism, activation of ClC-2 chloride channels to promote junctional protein trafficking, inhibition of myosin light chain kinase (MLCK) to prevent junctional opening, and upregulation of sealing claudins [5, 13, 15, 16].